

Healthtech Fund
A diversified portfolio of healthtech & life sciences investments.
Enter Secure Data Room
for key fund materials
- HomeFund Information
- HomePerformance Data
- HomeInvestor Rewards
- HomeFund Policies


- HomeInvest in ventures innovating in healthtech and life sciences
- Home~20-30 venture investments made over ~12-18 months— diversified by subsector, geography, region
- HomeReserves ~20% to pursue follow-on opportunities in the most promising portfolio investments
- HomeInvestments sourced by a team of dedicated investing professionals, our network of handpicked Scouts, AV’s 750k+ supporters, and other AV funds
- HomePart of Alumni Ventures, America's Largest Venture Firm for Individuals and a "Top 20 Venture Firm" (CB Insights '24)
See video policy below.
AV Co-Invests with Experienced Venture Firms
250+ investments with leading VCs and many with other top-quartile firms.


These leading venture firms have backed some of the most successful companies in the world.
Co-investors are shown for illustrative purposes only, do not represent all co-investors with which Alumni Ventures as invested, and are not necessarily indicative of future co-investors. The identity of a co-investor does not guarantee investment quality or performance.
Invest in Startups Like the Healthtech Apex 20
Accredited investors can invest in startups like the Healthtech Apex 20 with Alumni Ventures. Talk with a Senior Partner about our portfolio of over 250 companies from Oura to Precision to Cambrian to learn more about becoming an investor.
Or simply text us with you question for fast response
650-410-8600
Fundraise Timing & Loyalty Rewards
The fundraise deadlines of current and upcoming fund vintages are published below to help our investors with their personal venture allocation planning strategies. Read more about our Loyalty Rewards, Performance, and Fees.

About Alumni Ventures
We are a venture capital firm that provides accredited investors & institutions with access to professionally-managed, diversified venture portfolios. Our network is among the largest and most well-connected in the industry.
- Home#1 most active venture firm in the U.S., #3 in the world (PitchBook '22 & '23)
- Home$1.3B+ capital raised since founding in 2014
- HomeDiversified historical portfolio of 1,400+ venture-backed companies, adding ~250 / year
- Home10,500 individual accredited investors already trust us with their venture investing
- HomeTop 20 Venture Firm (CB Insights '24)
- HomeTop-quartile performance*
- HomeNetwork of 850k+ investors, entrepreneurs, & community members
- Home5 national offices & ~40 full-time venture investors
2022 Pitchbook Global League Tables, 2023 Pitchbook Global League Tables
The Top 20 venture investors in North America
*Top-Quartile for AV Fund vintages 2016-2020 as of September 30, 2024. Top Quartile ranking against Cambridge Associates’ peer group for venture capital, according to the Distributions to Paid-in Capital (DPI) metric. Top-Quartile for 2016 vintage was .77 for Cambridge Associates peer group and .72 for Alumni Ventures funds. Past performance does not guarantee future results.
HealthTech Fund News
Content at the intersection of entrepreneurship, venture capital, and specific industry sectors.
Healthtech Fund Portfolio
We invest alongside other established venture firms in a broad range of ventures to help build you a diversified venture portfolio.
- 3X Genetics
- Adora
- Alli Connect
- American Gene Technologies
- Andromeda Surgical
- Bionaut Labs
- Bionic Health
- Brave Health
- Dimension Inx
- Dropstat
- Earli
- eddii
- Emm
- Ezra
- Generate Biomedicines
- Genetesis
- HelixNano
- Hopscotch Health
- Jona
- Juvena Therapeutics
- Koala
- Miga Health
- Mign
- Nectero Medical
- Nextiles
- Pi Health
- Q Bio
- Rook
- Sami
- Satellite Bio
- SiPhox
- TFC Therapeutics
- Torch Technology
- Upside Health
- VenoStent
Access Fund Materials
- HomeFund information
- HomePerformance data
- HomeSpeak with our team
Review on your own, chat online, or speak with our team.